The selective inhibitors of GSDMD, inflammasomes, and caspase-1 are identified to ameliorate inflammation and thrombosis, and some of them exhibit excellent therapeutic efficacy in several autoimmune diseases. This evidence concerns the gene CASP1 and autoimmune disease.